Can a Month-Long pill tame fatty liver?

NCT ID NCT00666016

First seen Dec 26, 2025 · Last updated Apr 30, 2026 · Updated 16 times

Summary

This study tested a drug called TRO19622 in 22 adults with NASH, a type of fatty liver disease. Participants took either the drug or a placebo daily for one month to see if it safely lowered liver enzymes. The goal was to check short-term safety and effects on the liver, not to cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHU AMIENS, Service d'Hépato-Gastroentérologie

    Amiens, 80054, France

  • Centre Hospitalier de Hyères, Hôpital de Jour, Service d'Hépato-Gastro-Entérologie

    Hyères, 83407, France

  • Groupe Hospitalier Pitié-Salpétrière - Sce Hépato-Gastroentérologie - 47-83 Bd de l'Hôpital

    Paris, 75651, France

  • Hôpital Archet 2 - Pôle de Référence Hépatite C (Niveau -2) - 151, route Saint Antoine de Ginestière

    Nice, 06200, France

  • Hôpital Saint Joseph, Service d'Hépato-Gastro-Entérologie

    Marseille, 13285, France

Conditions

Explore the condition pages connected to this study.